Analyst price target range
Apnimed Price Target: $50.33 Average
Direct answer
Apnimed's average price target is $50.33.
The verified analyst range runs from $41.00 to $60.00.
The low target implies +60.4%, the high target implies +134.7%, and the range spans 74.3% of the current price.
Forecast evidence checked September 16, 2026.
Get free Apnimed email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $25.56
- Average price target
- $50.33
- High price target
- $60.00
- Low price target
- $41.00
- Low target gap
- +60.4%
- Target upside
- +96.9%
- High target gap
- +134.7%
- Target range width
- 74.3%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- September 16, 2026
- Valid through
- September 23, 2026
Explore related company data
Read the frequently asked questions.
What is Apnimed's average price target?
Apnimed's verified average price target is $50.33. The target range is $41.00 to $60.00.
How far are Apnimed's low and high targets from the recorded price?
The low target implies +60.4%, while the high target implies +134.7%.
How many analysts are included in Apnimed's consensus?
The verified consensus includes 3 analysts.
How is Apnimed's target upside or downside calculated?
The average target of $50.33 is divided by the recorded price of $25.56, then one is subtracted to produce +96.9%. This does not guarantee a future return.
When was Apnimed's analyst forecast verified?
The data was verified on 2026-09-16. The dataset is valid through 2026-09-23.